Severe vitamin D deficiency among heart and liver transplant recipients

Clinical Transplantation

Volumn 23, Issue 6, 2009, Pages 861-865

  Stein, Emily M ^a   Cohen, Adi ^a   Freeby, Matthew ^a   Rogers, Halley ^a   Kokolus, Shannon ^a   Scott, Vanessa ^a   Mancini, Donna ^a   Restaino, Susan ^a   Brown, Robert ^a   McMahon, Donald J ^a   Shane, Elizabeth ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Heart transplant; Liver transplant; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALENDRONIC ACID; CALCIUM; MULTIVITAMIN; PLACEBO; VITAMIN D; ZOLEDRONIC ACID; 25-HYDROXYVITAMIN D;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; FOLLOW UP; HEART FAILURE; INCIDENCE; LIVER FAILURE; MIDDLE AGED; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEW YORK; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 71149086209     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00989.x     Document Type: Article

References (26)

1. Dhesi JK, Bearne LM, Moniz C. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002, 17:891.
2. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999.
3. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842.
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357:266.
5. Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995, 53:599.
6. Shane E, Mancini D, Aaronson K. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997, 103:197.
7. Shane E, Silverberg SJ, Donovan D. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996, 101:262.
8. Monegal A, Navasa M, Guanabens N. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 2001, 12:484.
9. Stavroulopoulos A, Porter CJ, Roe SD, Hosking DJ, Cassidy MJ. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology (Carlton) 2008, 13:63.
10. Tripathi SS, Gibney EM, Gehr TW, King AL, Beckman MJ. High prevalence of vitamin D deficiency in African American kidney transplant recipients. Transplantation 2008, 85:767.
11. Segal E, Baruch Y, Kramsky R, Raz B, Ish-Shalom S. Vitamin D deficiency in liver transplant patients in Israel. Transplant Proc 2001, 33:2955.
12. Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 2006, 91:526.
13. Ewers B, Gasbjerg A, Moelgaard C, Frederiksen AM, Marckmann P. Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr 2008, 87:431.
14. Sadlier DM, Magee CC. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study. Clin Transplant 2007, 21:683.
15. Shane E, Addesso V, Namerow PB. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 2004, 350:767.
16. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999, 9:394.
17. Binkley N, Krueger D, Cowgill CS. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004, 89:3152.
18. Glendenning P, Noble JM, Taranto M. Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases. Ann Clin Biochem 2003, 40(Pt 5):546.
19. Crawford BA, Kam C, Pavlovic J. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2006, 144:239.
20. Breen TL, Shane E. Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency. J Clin Oncol 2004, 22:1531.
21. Perazella MA, Markowitz GS. Bisphosphonate nephrotoxicity. Kidney Int 2008, 74:1385.
22. Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol 2003, 9:1067.
23. Becker BN, Hullett DA, O'Herrin JK, Malin G, Sollinger HW, DeLuca H. Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation 2002, 74:1204.
24. Hullett DA, Cantorna MT, Redaelli C. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. Transplantation 1998, 66:824.
25. Briffa NK, Keogh AM, Sambrook PN, Eisman JA. Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. Transplantation 2003, 75:2133.
26. Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008, 17:348.